07.01.2026 • News

Mike Radossich Assumes Role of Syensqo CEO

Seasoned Syensqo business leader to guide the company’s next chapter.

Mike Radossich
Mike Radossich, CEO, Syensqo
© Syensqo

Syensqo recently announced that, further to the announcement made last fall, Mike Radossich has officially assumed the role of Chief Executive Officer and member of the Board of Directors. Mike succeeds Ilham Kadri, who will continue supporting the company as a special advisor to ensure a smooth transition of leadership. These changes are effective from January 1, 2026.

A long-standing Syensqo executive with extensive experience leading global businesses, Mike brings deep industry knowledge and a strong track record of operational excellence. He will steer Syensqo’s next phase as the company continues to focus on creating value for its stakeholders, accelerating sustainable, profitable growth, and driving long-term performance.

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.